Holding
COMPASS PathwaysCMPS
Furthest-along psilocybin company; Phase 3 for treatment-resistant depression underway.
weight · 14.00%·sector · Healthcare·exchange · NASDAQ
SPY+0.99%QQQ+0.93%NVDA−4.63%MSFT−3.93%AAPL+0.44%GOOGL+9.96%META−8.55%AMZN+0.77%TSLA+2.37%AVGO+2.95%SPY+0.99%QQQ+0.93%NVDA−4.63%MSFT−3.93%AAPL+0.44%GOOGL+9.96%META−8.55%AMZN+0.77%TSLA+2.37%AVGO+2.95%